Neutral
Eli Lilly's stock rises 0.41% after announcing drug discovery partnership
Eli Lilly's stock experienced a modest increase of 0.41% following the announcement of a new drug discovery partnership with Ginkgo Bioworks. This collaboration aims to enhance Lilly's capabilities in developing innovative therapeutics.
Key points
- Eli Lilly's stock rose 0.41% after announcing a drug discovery partnership with Ginkgo Bioworks.
Sources
AI-generated from public news sources. Not financial advice.
